EDITORIAL
The main scientific events in 2016 with Romanian medical oncologist participation
Alexandru Grigorescu
21 Aprilie 2017
I want to promote, in the following paragraphs, the main educational conferences from Europe and from all around the world in the oncology field. I will start with the Congress of European Association for Palliative Care (EAPC), which will be held in Madrid, in May 2017. The message of the president of this association is eloquent: “The growing recognition of the importance of palliative care is reflected in the title chosen for the upcoming 15th World Congress of the European Association for Palliative Care - ‘Progressing Palliative Care’. On behalf of the EAPC and the organizing committees, we would like to invite participants from all over the world to meet in the beautiful city of Madrid in 2017. Moreover, we are very delighted to announce that Her Royal Highness Queen Letizia of Spain will be the President of Honor for the EAPC Conference 2017”.
The next important event is The American Society for Clinical Oncology annual meeting. In 2016, this international conference, with a large participation from different countries, revealed many new data from numerous clinical trials, which will change the medical practice. Attendees claimed CME credits, downloaded a Certificate of Attendance, and provided feedback during the meeting.
Another important conference in which many oncologists from Romania participated in 2016 was the ESMO annual Congress. Across disciplines and across cultures, The European Society for Medical Oncology (ESMO) bridges the gap between researchers, clinicians and patients, and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.
Because lung cancer remains the main cause of mortality from cancer, I want to mention the Congress of International Association for the Study of Lung Cancer (IASLC), which was held in Vienna, in December 2016. Medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and patients came together and obtained exchange information on both state-of-the-art and advances in the management of lung cancer and other thoracic malignancies, considering both global and regional aspects.
Last but not least, I must mention the National Conference of Romanian National Society for Medical Oncology (SNOMR) - our association for medical oncology -, which reached new performance regarding the participation of international speakers and of Romanian medical oncologists. This conference was endorsed in 2016 by SIOG (International Society for Geriatric Oncology). Another important thing that I want to report is that, as a consequence of my dialog with ESMO, it was decided that our society (SNOMR) has the right to propose an ESMO National representative for 2017-2018.
In the end of this editorial, I must mention the success of our journal, Oncolog-Hematolog.ro, and of Versa Media, to be accepted in 2016 in an international database. The journal is under the auspices of SNOMR and The Institute of Oncology Bucharest.
Alexandru C. GRIGORESCU, MD, PhD
Editor-in-chief
The next important event is The American Society for Clinical Oncology annual meeting. In 2016, this international conference, with a large participation from different countries, revealed many new data from numerous clinical trials, which will change the medical practice. Attendees claimed CME credits, downloaded a Certificate of Attendance, and provided feedback during the meeting.
Another important conference in which many oncologists from Romania participated in 2016 was the ESMO annual Congress. Across disciplines and across cultures, The European Society for Medical Oncology (ESMO) bridges the gap between researchers, clinicians and patients, and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.
Because lung cancer remains the main cause of mortality from cancer, I want to mention the Congress of International Association for the Study of Lung Cancer (IASLC), which was held in Vienna, in December 2016. Medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and patients came together and obtained exchange information on both state-of-the-art and advances in the management of lung cancer and other thoracic malignancies, considering both global and regional aspects.
Last but not least, I must mention the National Conference of Romanian National Society for Medical Oncology (SNOMR) - our association for medical oncology -, which reached new performance regarding the participation of international speakers and of Romanian medical oncologists. This conference was endorsed in 2016 by SIOG (International Society for Geriatric Oncology). Another important thing that I want to report is that, as a consequence of my dialog with ESMO, it was decided that our society (SNOMR) has the right to propose an ESMO National representative for 2017-2018.
In the end of this editorial, I must mention the success of our journal, Oncolog-Hematolog.ro, and of Versa Media, to be accepted in 2016 in an international database. The journal is under the auspices of SNOMR and The Institute of Oncology Bucharest.
Alexandru C. GRIGORESCU, MD, PhD
Editor-in-chief
Articole din ediția curentă
INTERVIEWS
Prof. dr. Marc Peeters Oncology Department, University of Antwerp, Belgium
...
INTERVIEWS
Prof. dr. Siegfried Segaert Dermatology Department, University Hospital Leuven, Belgium
...
REVIEW
Imunoterapia în cancerul pancreatic - un pas înainte în viitor
Cristina David
De zeci de ani a existat o permanentă preocupare pentru a descoperi relația între tumoră și sistemul imun. Ultimele descoperiri au permis folosirea principiilor imunologice și au introdus noi căi prin care atât răspunsul imun nespecific înnăscut, cât și cel specific dobândit pot fi folosite pentru a crește ef...Articole din edițiile anterioare
SHORT REVIEW
New approaches to colorectal cancer
Alexandru Grigorescu
Cancerul colonului reprezintă una din cele mai frecvente localizări ale cancerului în epoca noastră....
EDITORIAL
A new achievement of the authors and editors of “Oncolog-Hematolog.ro” journal
Alexandru Grigorescu
I believe that the indexing of the journal Oncolog-Hematolog.ro in Index Copernicus is an event that must be marked in this editorial. This is due to the joint efforts of the authors of the articles and the editor. I will present below the score obtained by our national oncology journal which shows that we ar...
REVIEW